Blue Owl Capital is a leading alternative asset manager specializing in private market investments, including direct lending, minority equity financing, and real estate capital solutions. With a focus on innovation and partnership, the company manages a diverse range of assets for institutional investors, financial advisors, and individual investors globally. Founded in 2021, Blue Owl is publicly traded on the NYSE under the symbol OWL.
- Forex Trading
- Financial Services
- Global Markets
- Commodities
- Cryptocurrencies
Recent Transactions involving Blue Owl Capital
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
QuVa Pharma Completes Acquisition of LogicStream Health |
LogicStream Health |
QuVa Pharma |
Blue Owl Capital |
Healthcare Technology |
|
|
|
||
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
||
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →